Magnetic Nanoparticle Delivery for CRISPR Stem Cell Editing
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current gene delivery methods, particularly those using viral vectors for CRISPR-Cas9 systems, face limitations such as low delivery efficiencies, immunogenicity, and the risk of mutagenesis, necessitating the development of more effective non-viral delivery systems for genetic editing applications.
Innovation Solution
A magnetic-assisted nanoparticle delivery system comprising a magnetic core-shell nanoparticle with a silica shell, cationic polymer layers, and encapsulated polynucleotides, which utilizes magnetofection and magnetic-activated cell sorting to enhance the intracellular delivery and editing efficiency of CRISPR-Cas9 components.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If viral vectors (AAV, lentiviral) are used to deliver CRISPR-Cas9 components, then delivery specificity is improved, but delivery efficiency is limited and immunogenicity/mutagenesis risks increase
Solution Approach 1:
The patent replaces the biological viral vector system with a magnetic nanoparticle-based physical delivery system. The nanoparticle core-shell structure with magnetic properties allows for magnetic field-guided delivery to target cells, eliminating the need for viral vectors and their associated immunogenicity and mutagenesis risks while maintaining delivery specificity through magnetic targeting.
Solution Approach 2:
The patent introduces magnetic nanoparticles as intermediary carriers between the delivery system and CRISPR-Cas9 components. These nanoparticles serve as a non-viral vector that can be magnetically guided to target cells and deliver genetic material, acting as a safe alternative to viral vectors without compromising delivery efficiency.
2Object-affected harmful factors
If non-viral delivery methods (nano-/microcarriers) are used, then immunogenicity and mutagenesis risks are reduced, but delivery efficiency remains low
Solution Approach 1:
The patent modifies the physical and chemical parameters of the nanoparticle system, including core-shell structure composition, magnetic properties, surface charge, and size distribution, to optimize cellular uptake and intracellular delivery. These parameter optimizations significantly enhance delivery efficiency while maintaining the non-viral safety profile.
Solution Approach 2:
The patent employs a composite nanoparticle structure consisting of a magnetic core surrounded by functional shells and coated with cationic polymers. This composite architecture combines the magnetic targeting capability with enhanced cellular interaction properties, achieving both high delivery efficiency and low immunogenicity simultaneously.
3Productivity
If magnetic core-shell nanoparticles with cationic polymer layers are used, then intracellular delivery efficiency is improved, but system complexity increases
Solution Approach 1:
The patent divides the nanoparticle delivery system into distinct functional segments: a magnetic core for targeting, a shell layer for structural integrity, and cationic polymer coatings for cellular interaction. This segmentation allows each component to be optimized independently while working together to achieve high intracellular delivery efficiency.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This system significantly improves the transfection efficiency and biocompatibility of CRISPR-Cas9 systems, enabling efficient gene editing in stem cells and potentially treating genetic disorders like Rett syndrome with high accuracy and minimal toxicity.
Implementation Method 1
which utilizes magnetofection and magnetic-activated cell sorting to enhance the intracellular delivery and editing efficiency of CRISPR-Cas9 components
Implementation Method 2
which utilizes magnetofection and magnetic-activated cell sorting to enhance the intracellular delivery and editing efficiency of CRISPR-Cas9 components
Implementation Method 3
the one or more polynucleotides are associated through electrostatic interactions with the inner cationic polymer layer
Data Source
AI summary
This disclosure provides a novel magnetic nanoparticle-assisted genome editing (MAGE) platform, which significantly improves transfection efficiency and biocompatibility in stem cells as well as the efficiency of CRISPR-Cas systems. Due to the great potential of CRISPR-Cas systems, the disclosed MAGE platform can be used for a host of applications in stem cell therapy for genetic disorders.